Summit Investment Advisors »

Neurocrine Biosciences shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 22k 131.76
2023-09-30 $2.5M 22k 112.50
2023-06-30 $2.3M 24k 94.30
2023-03-31 $2.5M 25k 101.22
2022-12-31 $2.7M 25k 108.75
2022-09-30 $2.6M 25k 106.20
2022-06-30 $2.5M 25k 97.46
2022-03-31 $2.4M 25k 93.75
2021-12-31 $2.2M 25k 85.16
2021-09-30 $2.4M 25k 95.93
2021-06-30 $2.5M 26k 97.32
2021-03-31 $2.5M 26k 97.25
2016-03-31 $263k 6.7k 39.48
2015-12-31 $377k 6.7k 56.59
2015-09-30 $262k 6.6k 39.75
2015-06-30 $315k 6.6k 47.79
2015-03-31 $296k 7.4k 39.76